首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1619123

單採術市場規模、佔有率、成長分析，按產品、按程序、按技術、按應用、按最終用戶、按地區 - 行業預測，2024-2031

Apheresis Market Size, Share, Growth Analysis, By Product (Apheresis Disposals, Apheresis Devices), By Procedure (Plasmapheresis, Plateletpheresis), By Technology, By Application, By End user, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球單採市場規模為28億美元，從2023年的31億美元成長到2031年的72億美元，在預測期間（2024-2031年）年複合成長率為11.1%。

由於疾病盛行率不斷上升以及對安全血液成分的需求不斷成長，預計單採血液成分市場將顯著成長。單採技術的創新進步提高了程序的有效性，有利的報銷政策和增加的資金籌措進一步增強了市場動態。單採術已作為多種疾病的主要或輔助性治療，包括血栓性血小板低下紫斑症、自體免疫疾病和敗血症，其多功能性和療效已凸顯，臨床應用不斷擴大。此外，持續的產品創新和監管核准對於推動市場擴張至關重要。然而，為了維持市場成長勢頭，必須解決缺乏熟練專業人員、血液污染問題和高昂手術成本等挑戰。

Terumo BCT, Inc.（日本）
費森尤斯醫療（德國）
Haemonetics 公司（美國）
百特國際（美國）
旭化成醫療株式會社（日本）
鐘化株式會社（日本）
Cerus 公司（美國）
B.Braun Melsungen AG（德國）
Macopharma SA（法國）
川澄研究所（日本）
日機裝株式會社（日本）
Medica SPA（義大利）
Miltenyi BIoTec（德國）
大塚控股（JIMRO）（日本）
細胞吸附劑公司（美國）
Bioelettronica Srl（義大利）
廣州大吉醫療（中國）
北京中科世凱科技（中國）
Infomed SA（瑞士）
海爾生物醫藥（中國）

結論和建議

簡介目錄

Product Code: SQMIG35D2190

Global Apheresis Market size was valued at USD 2.8 billion in 2022 and is poised to grow from USD 3.1 billion in 2023 to USD 7.2 billion by 2031, growing at a CAGR of 11.1% during the forecast period (2024-2031).

The apheresis market is poised for substantial growth, fueled by an increasing prevalence of diseases and the heightened demand for secure blood components. Innovative advancements in apheresis techniques are enhancing procedural efficacy, while favorable reimbursement policies and increased funding further bolster market dynamics. The application of apheresis as a primary or adjunct therapy for a range of conditions-such as thrombotic thrombocytopenic purpura, autoimmune disorders, and sepsis-highlights its versatility and effectiveness, driving wider clinical adoption. Furthermore, ongoing product innovations and regulatory approvals are pivotal in propelling market expansion. However, challenges including a shortage of skilled professionals, blood contamination concerns, and high procedural costs must be addressed to maintain the market's growth momentum.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Apheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Apheresis Market Segmental Analysis

Global Apheresis Market is segmented by product, procedure, technology, application, end user and region. Based on Product, the market is segmented into Apheresis Disposals and Apheresis Devices. Based on Procedure, the market is segmented into Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Photopheresis, LDL-apheresis, and Others. Based on technology, the market is segmented into Centrifugation, and Membrane Separation. Based on application, the market is segmented into Renal Diseases, Neurology, Haematology, Cancer, Autoimmune Diseases, Cardiovascular Diseases and others. Based on end user, the market is segmented into Blood Collection Centers & Blood Component Providers, Hospitals & Transfusion Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Apheresis Market

The global apheresis market is significantly propelled by the growing prevalence of chronic diseases, including cancer, autoimmune disorders, and cardiovascular issues. As these conditions become more widespread, the demand for apheresis procedures increases, as they are vital in managing these health challenges by selectively extracting or collecting specific blood components. This process not only enhances patient outcomes but also supports the trend toward personalized medicine. By allowing for tailored treatments that target individual patient needs-either through the removal of harmful substances or the collection of specific blood components for further therapeutic or research purposes-apheresis aligns well with modern healthcare approaches focused on personalization and precision.

Restraints in the Global Apheresis Market

The global apheresis market faces several restraints that impede its growth. One of the foremost challenges is the high cost linked to apheresis devices and the therapeutic procedures involved. These costs, combined with the complexities of installation and maintenance of such equipment, create barriers to entry for many healthcare facilities. Furthermore, the substantial financial investment needed for both acquiring apheresis devices and executing therapeutic procedures can deter wider adoption. Additionally, a lack of awareness surrounding apheresis among potential blood donors contributes to lower participation rates in apheresis-based blood donation, further obstructing market expansion and limiting its overall potential.

Market Trends of the Global Apheresis Market

The Global Apheresis market is witnessing a significant trend toward the adoption of personalized medicine and targeted therapies, driven by rapid advancements in healthcare technologies. As clinicians increasingly emphasize individualized treatment approaches, the demand for apheresis procedures tailored to specific patient profiles is rising. This shift is enhancing therapeutic efficacy by allowing for more precise interventions based on patient-specific medical conditions and genetic characteristics. Additionally, the integration of innovative apheresis technologies is further supporting clinical efforts to improve patient outcomes. Consequently, the market is evolving, presenting lucrative opportunities for stakeholders who can adapt to these personalized healthcare paradigms.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Regulatory Landscape
Top Investment Pockets
Market Attractiveness Index
Technology Advancement
Market Ecosystem
Patent Analysis
Value Chain Analysis
Case Study Analysis
Macro-Economic Indicators

Global Apheresis Market Size by Product & CAGR (2024-2031)

Market Overview
Apheresis Disposals
- Centrifugal Apheresis Devices
- Membrane Separators
Apheresis Devices

Global Apheresis Market Size by Procedure & CAGR (2024-2031)

Market Overview
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Photopheresis
LDL-apheresis
Others

Global Apheresis Market Size by Technology & CAGR (2024-2031)

Market Overview
Centrifugation
- Continuous Flow Centrifugal
- Intermittent Flow Centrifugation
Membrane Separation

Global Apheresis Market Size by Application & CAGR (2024-2031)

Market Overview
Renal Diseases
Neurology
Haematology
Cancer
Autoimmune Diseases
Cardiovascular Diseases
Others

Global Apheresis Market Size by End-User & CAGR (2024-2031)

Market Overview
Blood Collection Centers & Blood Component Providers
Hospitals & Transfusion Centers
Others

Global Apheresis Market Size & CAGR (2024-2031)

North America (Product, Procedure, Technology, Application, End-User)
- US
- Canada
Europe (Product, Procedure, Technology, Application, End-User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Product, Procedure, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Product, Procedure, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Procedure, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Terumo BCT, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haemonetics Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Medical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerus Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macopharma SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kawasumi Laboratories (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikkiso Co., Ltd (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medica SPA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Holdings (JIMRO) (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytosorbents Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioelettronica S.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guangzhou Daji Medical (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing ZKSK Technology (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Infomed SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haier Biomedical (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments